NV-5138

· Navitor Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NV-5138, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression [Phase 2]